4Albert S. Cost-effective management of recalcitrant diabetic foot ulcers.Clin Podiatr Med Surg, 2002,19:483-491.
5Bennett SP, Griffiths GD, Schor AM, et al. Growth factors in the treatment of diabetic foot ulcers. Br J Surg, 2003,90:133 -146.
6Ford AC, Grandis JR. Targeting epidermal growth factor receptor in head and neck cancer. J Head Neck, 2003,25:67-73.
7Jurgen K, Ulrich K, Mexander D, et al. Buried chip skin grafting in neumpathic diabetic foot ulcers following vacuum-assisted wound bed preparation:enhancing a classic surgical tool with novel technologies. Int J Low Extrem Wounds,2004,3: 168-171.
8Lobmann R, Schultz G, Lehnert H. Molecular fundamentals of wound healing in diabetic foot syndrome. Med Klin (Munich), 2003,98 : 292-301.
9Galkowska H, Wojewodzka U, Olszewski WL. Chemokines, cytokines,and growth factors in keratinocytes and dermal endothelial cells in the margin of chronic diabetic foot ulcers. Wound Repair Regen,2006, 14:558-565.
10Potero-Otin M, Pamplona R, Bellmunt MJ, et al. Advanced glycation end product precursors impair epidermal growth factor receptor signaling. Diabetes,2002,51 : 1535-1542.